Hyperandrogenism clinical trials

Explore recruiting hyperandrogenism clinical trials.

Recruiting hyperandrogenism studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hyperandrogenism trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multicentre, prospective, open-label, non-comparative study to evaluate menstrual bleeding typology, tolerability, and compliance during a monophasic hormonal contraceptive treatment with norgestimate + ethinylestradiol in Italy.”

Italy

Therapeutic use (Phase IV) EU CTIS Study details

A Clinical Trial of Tirzepatide (LY3298176) in Subjects With Overweight or Obesity and PCOS-related Ovarian Dysfunction (PERIODS)

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Hyperandrogenism trials by city

Hyperandrogenism in Toronto Hyperandrogenism in Vancouver Hyperandrogenism in Montreal Hyperandrogenism in Calgary Hyperandrogenism in Edmonton Hyperandrogenism in Ottawa Hyperandrogenism in Winnipeg Hyperandrogenism in Quebec City Hyperandrogenism in Hamilton Hyperandrogenism in Kitchener Hyperandrogenism in London Hyperandrogenism in Halifax Hyperandrogenism in New York Hyperandrogenism in Los Angeles Hyperandrogenism in Chicago Hyperandrogenism in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease